Eur Rev Med Pharmacol Sci 2018; 22 (5): 1171-1174
DOI: 10.26355/eurrev_201803_14453

MicroRNA-552 in colorectal cancer with poor prognosis. Its role as a novel molecular biomarker

A. Scano, D. Ratto, A. Occhinegro, A. Pedroncelli, P. Rossi

Molecular Biology Service, Department of Surgical Sciences, University of Cagliari, Cagliari, Italy. paola.rossi@unipv.it

Free PDF Download

To cite this article

A. Scano, D. Ratto, A. Occhinegro, A. Pedroncelli, P. Rossi
MicroRNA-552 in colorectal cancer with poor prognosis. Its role as a novel molecular biomarker

Eur Rev Med Pharmacol Sci
Year: 2018
Vol. 22 - N. 5
Pages: 1171-1174
DOI: 10.26355/eurrev_201803_14453

Keywords Related articles:

  1. Increased expression of miR-552 acts as a potential predictor biomarker for poor prognosis of colorectal cancer
  2. MicroRNA-1908 is a biomarker for poor prognosis in human osteosarcoma
  3. Association of the upregulation of LncRNA00673 with poor prognosis for colorectal cancer
  4. Expression features of CXCR5 and its ligand, CXCL13 associated with poor prognosis of advanced colorectal cancer
  5. Downregulation of long non-coding RNA LINC01133 is predictive of poor prognosis in colorectal cancer patients